Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Insufficient Evidence to Rate Effectiveness for
Healthcare professionals must weigh the maternal need for glycaemic or weight control against the theoretical risks to the infant, recognising that uncontrolled diabetes itself poses significant health risks to the mother
November 2025 : Eli Lillys obesity and diabetes drug Mounjaro (tirzepatide) became Indias top-selling pharmaceutical brand by value, generating about INR 1 billion ( US$ 11.38 million ) in monthly sales
Most plans accept claims within 90 days to one year of purchase, but verify your specific deadline with your employer or plan provider
US$ 25.66
US$ 22.07
US$ 27.46
US$ 29.81
US$ 21.33
US$ 29.76
US$ 21.18
US$ 22.04
US$ 28.73
